USE OF CIS-EPOXYEICOSANTRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO REDUCE PULMONARY INFILTRATION BY NEUTROPHILS
申请人:Hammock Bruce D.
公开号:US20100317733A1
公开(公告)日:2010-12-16
It has now been discovered that inhibitors of soluble epoxide hydrolase (“sEH”) are useful in reducing the severity of or inhibiting the progression of obstructive pulmonary diseases, restrictive airway diseases, and asthma. Administering a cis-epoxyeicosantrienoic acid (“EET”) in addition to the inhibitor is at least additive, and may be synergistic, in reducing or inhibiting these conditions and diseases, as measured by reduced numbers of neutrophils present in the lung. The inhibitor of sEH may be a nucleic acid, such as a small interfering RNA.
现在已经发现,可溶性环氧酯酶(“sEH”)的抑制剂对减轻或抑制阻塞性肺疾病、限制性气道疾病和哮喘的进展非常有用。除抑制剂外,给予顺式环氧二十碳三烯酸(“EET”)至少具有加成作用,可能对减轻或抑制这些疾病有协同作用,如通过减少肺部中中性粒细胞的数量来衡量。sEH的抑制剂可以是核酸,例如小干扰RNA。